학술논문

Real-time quantitative PCR with SYBR Green I detection for estimating copy numbers of nine drug resistance candidate genes in Plasmodium falciparum
Document Type
article
Source
Malaria Journal. 5(1)
Subject
Vector-Borne Diseases
Malaria
Biotechnology
Antimicrobial Resistance
Rare Diseases
Genetics
Development of treatments and therapeutic interventions
5.1 Pharmaceuticals
Infection
Good Health and Well Being
Animals
Benzothiazoles
Biomarkers
Tumor
DNA Primers
DNA
Protozoan
Diamines
Drug Resistance
Fluorescent Dyes
Gene Dosage
Genes
MDR
Glutathione Reductase
Humans
Organic Chemicals
Plasmodium falciparum
Polymerase Chain Reaction
Quinolines
Reproducibility of Results
Sarcoplasmic Reticulum Calcium-Transporting ATPases
Sensitivity and Specificity
Tumor Protein
Translationally-Controlled 1
Microbiology
Medical Microbiology
Public Health and Health Services
Tropical Medicine
Language
Abstract
BackgroundEvaluating copy numbers of given genes in Plasmodium falciparum parasites is of major importance for laboratory-based studies or epidemiological surveys. For instance, pfmdr1 gene amplification has been associated with resistance to quinine derivatives and several genes involved in anti-oxidant defence may play an important role in resistance to antimalarial drugs, although their potential involvement has been overlooked.MethodsThe DeltaDeltaCt method of relative quantification using real-time quantitative PCR with SYBR Green I detection was adapted and optimized to estimate copy numbers of three genes previously indicated as putative candidates of resistance to quinolines and artemisinin derivatives: pfmdr1, pfatp6 (SERCA) and pftctp, and in six further genes involved in oxidative stress responses.ResultsUsing carefully designed specific RT-qPCR oligonucleotides, the methods were optimized for each gene and validated by the accurate measure of previously known number of copies of the pfmdr1 gene in the laboratory reference strains P. falciparum 3D7 and Dd2. Subsequently, Standard Operating Procedures (SOPs) were developed to the remaining genes under study and successfully applied to DNA obtained from dried filter blood spots of field isolates of P. falciparum collected in São Tomé & Principe, West Africa.ConclusionThe SOPs reported here may be used as a high throughput tool to investigate the role of these drug resistance gene candidates in laboratory studies or large scale epidemiological surveys.